Peer reviewed
Immune Modulation with Thymosin Alpha 1
King R, Tuthill C (2016) comprehensive review (PMID 26653168) of thymosin alpha-1's immune-modulating mechanism, clinical development history, and therapeutic applications including hepatitis, oncology, and sepsis.
Expert Review of Clinical Immunology (PubMed)Published May 1, 2016Accessed Jul 1, 2026
Registry record
Source metadata
- Publisher
- Expert Review of Clinical Immunology (PubMed)
- Source type
- Peer reviewed
- Registry ID
pubmed-king-tuthill-2016
Source usage
Linked from 6 pages
Compound
Thymosin Alpha-1
Evidence curationBest Peptides for Immune Support
Evidence curationBest Peptides for Inflammation Research
GuideFDA Enforcement Timeline: Major Actions on Peptides and Compounding
GuidePeptide Category Explainers: How Every Compound Class on This Site Is Defined
GuidePeptide Half-Life Reference Table
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.